Table 2 Characteristics of included studies
Study, Year | Design | Population | Simple size-n (ET/OSR) | Target site | Traumatic type § | Mean age-y (ET/OSR) | Male-n (ET/OSR) |
|---|---|---|---|---|---|---|---|
Potter, 2021 23 | R | Adult | 157/628 | iSFA/PA/SFA/PA | B + P | 40/39 | 125/503 |
Abdou(P) †, 2021 25 | R | Adult | 198/198 | IA | P | 28/27.33 | 179/184 |
Abdou(B)‡, 2021 25 | R | Adult | 335/335 | IA | B | 45/43.67 | 196/196 |
Degmetich, 2020 22 | P | Both | 390/1865 | SFA | B + P + U | 44.9/32.5 | 285/1660 |
Ratnasekera, 2020 30 | R | Adult | 30/18 | iSFA/PA | P | 25.33/28.67 | 26/18 |
Maithel, 2020 29 | R | Pediatric | 6/31 | PA | B + P | 16/15 | 6/26 |
Butler, 2019 27 | R | Adult | 37/456 | SFA | B + P + U | 50.9/36.3 | 22/387 |
Wahab, 2019 24 | R | Adult | 10/10 | FA | NA | 28.5/27.5 | 10/10 |
Branco, 2017 26 | R | Pediatric | 120/616 | CFA/SFA/PA/ATA/PTA | NA | NA | NA |
Branco, 2014 13 | R | NA | 128/128 | CFA/SFA/PA/ATA/PTA | NA | NA | NA |
Dua, 2014 28 | R | NA | 19/24 | PA | NA | NA | NA |
Banion, 2021 42 | C | Adult | NA/302 | PA | B + P | NA/32 | 239/302 |
Jiang, 2021 8 | C | Adult | 46/NA | iPA | B + P | 50.6/NA | 32/NA |
Hundersmarck, 2021 37 | C | NA | NA/16 | PA | B | NA | NA |
Georgakarakos, 2021 36 | C | Adult | 17/NA | CIA/EIA/CFA/SFA/PA/ATA/PTA | B + P | NA | NA |
Asensio, 2020 32 | C | Both | NA/76 | PA | B + P | NA/29 | NA/58 |
Rehman, 2020 45 | C | Adult | NA/40 | PA | B + P | NA/32 | NA/100 |
Sharrock, 2019 12 | C | NA | NA/596 | CIA/EIA/CFA/SFA/PFA/PA/ ATA/PTA/ PA†| P | NA/25.19 | NA |
Prieto, 2019 44 | C | Pediatric | NA/42 | PTA /ATA | NA | NA | NA |
Magnotti (P)†, 202040 | C | Adult | NA/123 | PA | P | NA/32 | NA/116 |
Magnotti (B)‡, 202040 | C | Adult | NA/91 | PA | B | NA/38 | NA/69 |
Mousa, 2018 41 | C | Pediatric | NA/76 | SFA/PA/PTA | B + P | NA | NA |
Åžahin, 2018 46 | C | Adult | NA/21 | NA | NA | NA | NA |
Kufner, 2015 39 | C | Adult | 30/NA | IA/ PA | NA | 71/NA | 36.7/NA |
Lang, 2015 10 | C | NA | NA/64 | PA | NA | NA/44 | NA/44 |
Dua, 2014 34 | C | Adult | NA/64 | PA | NA | NA/28 | NA/28 |
Sciarretta, 2014 47 | C | Pediatric | NA/32 | PA/ATA/PTA/ PA* | B + P | NA /14.7 | NA /17 |
Bernhoff, 2013 33 | C | Adult | NA/31 | PA | NA | NA | NA |
Dua, 2012 35 | C | NA | NA/72 | CFA/SFA/PA/TA | NA | NA | NA |
Trellopoulo-s, 2012 48 | C | NA | NA/13 | NA | NA | NA | NA |
Pourzand, 2010 43 | C | Both | NA/72 | PA | B | NA/34 | NA/70 |
Huynh, 2006 38 | C | Both | NA/57 | FA /PA | B + U | NA/31 | NA/44 |
White, 2006 49 | C | NA | 44/NA | IA/ FA | NA | NA | NA |
Aksoy, 2005 31 | C | NA | 10/NA | NA | P | 21.58/NA | NA |